TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Curaleaf Holdings ( (TSE:CURA) ).
Curaleaf Holdings has entered into a binding agreement to acquire The Cannabist Company’s Virginia assets, including a cultivation facility and multiple dispensaries. This acquisition, expected to close in early 2026, aims to strengthen Curaleaf’s market position in Virginia, subject to a go-shop period and potential competing bids.
The most recent analyst rating on (TSE:CURA) stock is a Hold with a C$3.00 price target. To see the full list of analyst forecasts on Curaleaf Holdings stock, see the TSE:CURA Stock Forecast page.
Spark’s Take on TSE:CURA Stock
According to Spark, TipRanks’ AI Analyst, TSE:CURA is a Neutral.
Curaleaf Holdings’ overall stock score is primarily impacted by its financial performance and valuation concerns. The company faces significant financial challenges, including declining revenues and negative profitability, which are compounded by a negative P/E ratio. Technical analysis indicates bearish momentum, further weighing on the stock’s outlook. Despite some positive signals from international growth, the overall sentiment remains cautious.
To see Spark’s full report on TSE:CURA stock, click here.
More about Curaleaf Holdings
Curaleaf Holdings, Inc. is a leading international provider of consumer cannabis products, known for its quality, expertise, and reliability. The company operates across medical and adult-use markets with a strong presence in Europe, Canada, and Australasia, offering a wide range of products through its brands such as Curaleaf, Select, Grassroots, and others.
Average Trading Volume: 931,216
Technical Sentiment Signal: Sell
Current Market Cap: C$2.62B
Find detailed analytics on CURA stock on TipRanks’ Stock Analysis page.